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It has been hypothesized that decreased fer-
tility and increased sexual dysfunction in
wildlife are associated with endocrine-relat-
ed toxicants (1,2). For example, fish
exposed to various endocrine-mimicking
compounds (e.g., TCDD, polychlorinated
biphenyls, or o,p'-DDT) exhibit smaller
gonads, reduced egg output, abnormal plas-
ma sex hormone concentrations, and
greater embryonic mortality (3,4). Various
xenoestrogens, such as o,p'-DDT (5) and
octyl phenol (OP) (6) that compete with
the natural estrogen 17,B-estradiol for bind-
ing to the estrogen receptor have been iden-
tified. The estrogen receptor is a member of
a superfamily of transcription factors that
transduce their intracellular signals by bind-
ing lipophilic hormones. Natural estrogens
play a major role in vertebrate reproduc-
tion. Estrogens are also associated with an
increased risk for cancers of the breast,
ovary, and endometrium in human popula-
tions (7,8). It has been hypothesized that
the effects observed in wildlife exposed to
xenoestrogens could serve as biomarkers for
public health (1,2>9).
Endocrine signaling is a complex
process involving synthesis, release, uptake,
and the eventual degradation ofhormones.
The physiological response generated in
the target cell due to a hormone is a com-
posite of these processes. Thus, the effec-
tive concentration is that concentration
capable of inducing a specific response in
the target cell and, in the case of estradiol,
is modified by binding to serum proteins
such as albumin and sex hormone binding
globulin (SHBG). Albumin is a nonspecif-
ic binding protein with a low affinity and
specificity for estradiol, whereas SHBG has
a high affinity and specificity for estradiol.
The synthetic estrogen diethylstilbestrol
(DES) has been shown to have a much
lower affinity for SHBG than estradiol.
Therefore, at equivalent concentrations of
estradiol and DES, the concentration of
DES at the target cell will be significantly
greater than that ofestradiol.
Recent studies examining a number of
wildlife species have demonstrated that
exposure to contaminants can permanently
modify the embryonic development ofthe
reproductive and endocrine systems (2).
One well-documented case is that of the
alligators living in Lake Apopka, Florida.
The alligators were exposed to a number of
anthropogenic contaminants derived from
agricultural and municipal activity as well as
a major pesticide (dicofol and DDT) spill
(10-12). Alligator eggs from Lake Apopka
show elevated levels of p,p'-DDE, p,p'-
DDD, dieldrin, and various polychlorinat-
ed biphenyls (PCBs) (13). Hatchlings from
these eggs exhibited abnormal gonadal
anatomy, gonadal steroidogenesis, and plas-
ma sex steroid concentrations (11,12).
Recent data suggest that the abnormalities
in plasma sex-steroid concentrations are
partly due to modifications in the serum
binding capabilities for the various sex
steroids (12). Variations in serum binding
will modify circulating sex steroid levels and
will also modify the transport and cellular
availability of various xenoestrogens.
Although serum binds naturally occurring
sex steroids, it does not appear that serum
proteins interact, to any great extent, with
synthetic estrogens, such as DES (14) or
with environmental estrogens such as op'-
DDT (15).
In order to measure the estrogenicity of
a certain compound, several factors must be
taken into account: 1) affinity of the com-
pound for the estrogen receptor, 2) accu-
mulation of the compound in the environ-
ment and the body, 3) degradation or
metabolism of the compound in the envi-
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ronment and body, and 4) the availability
ofthe compound to the target cell. The E-
screen assay has been developed to identify
environmental compounds that demon-
strate estrogenicity (16,17). This assay uses
the proliferation of MCF7 breast carcino-
ma cells as a marker of estrogenicity. We
created a simpler approach, the yeast estro-
gen screen (YES), using a yeast strain
responsive to estrogens. Yeast do not con-
tain sex steroid or thyroid hormone recep-
tors, except those transfected into the
strain, but they possess proteins homolo-
gous to mammalian cells that are required
for activated transcription. In this paper,
we present the use of the YES system for
the screening ofxenoestrogens. In addition,
the YES system was used to assess the rela-
tive bioavailability ofestradiol compared to
the synthetic estrogens DES, o,p'-DDT,
and OP.
Materials and Methods
We purchased 17,-estradiol, DES, o,p'-
DDT [1,1,1-trichloro-2-(p-chlorophenyl)-
2-(o-chlorophenyl)ethane], 4-OP, human
albumin, and human SHBG from Sigma
Chemical Co. (St. Louis, Missouri). The
yeast reporter plasmid YRPE2, containing
2 EREs linked to the lacZgene, was a gift
from B. O'Malley and Z. Nawaz, Baylor
Medical College.
The yeast expression plasmid,
pSCW231-hER, was created by ligating an
EcoRl fragment of the cDNA of the hER
into pSCW231. Theyeast strain BJ2407 was
transformed with pSCW231 or pSCW231-
hER and YRPE2 using methodology
describedbyChen et al. (18). Transformants
were selected for 3 days at 300C on plates by
tryptophan anduracilauxotrophy.
A single yeast colony was grown in SD-
uracil, tryptophan medium overnight at
30°C. The next day, 50 ml of the
overnight culture was diluted into 200 ml
of fresh medium and grown overnight in
the presence of the test compounds. All
compounds were prepared in dimethylsul-
foxide (DMSO) and added such that the
concentration of DMSO did not exceed
2%. Human albumin and SHBG were dis-
solved in SD-uracil, tryptophan and added
at the appropriate concentration to the cul-
ture. Alligator (Alligator mississippiensis)
serum was obtained from a gravid, adult
female collected under permit from the
Florida Game and Fresh Water Fish
Commission. Samples were taken from the
postcranial sinus and allowed to clot for 2
hr at room temperature. The serum tubes
were centrifuged and sera were collected,
snap frozen in liquid nitrogen, and stored
at -700C. The human serum was taken
from tWO adult men and two adult women.
Samples were collected from the brachial
blood vessels and treated as described
above. Before use in theYES system, serum
was charcoal-stripped by incubation with
5% Norit-A overnight at 40C. The serum
was separated from the charcoal by cen-
trifugation and the protein concentration
determined using the Bio-Rad (Hercules,
California) protein assay. The protein con-
centration of the alligator serum was 70
mg/ml and of the human serum was 55
mg/ml. The inclusion of albumin, SHBG
and sera from human and alligator at the
concentrations used did not significantly
affect the growth ofthe yeast.
For the ,B-galactosidase assays, the yeast
cells were collected by centrifugation and
resuspended in 700 ml of Z-buffer (60
mM Na2HPO4, 40 mM NaH2PO4, 10
mM KCl, 1 mM MgSO4, 35 mM P-mer-
captoethanol). The cells were permeabi-
lized by the addition of6 ml ofCHCl3 and
4 ml of 0.1% sodium dodecyl sulfate fol-
lowed by vortexing for 25 sec. The reac-
tions were equilibrated at 30°C for 10 min,
then 160 ml ONGP (4 mg o-nitrophenyl
,B-D-galactopyranoside/ml Z-buffer) was
added and the reactions returned to 30°C.
The reactions were terminated by the addi-
tion of400 ml IM NaCO3, the cell debris
was removed by centrifugation at 15,000g
for 5 min, and the absorbance (A) at 420
nm was measured. Miller units were deter-
mined using the following formula:
[A420/(A600 of 1/10 dilution ofcells x vol-





The yeast strains SCW-ERE and hER-ERE
were grown overnight in the presence or
absence of 17f-estradiol, DES, o,p'-DDT,
OP, antiestrogen ICI 164,384, dexametha-
sone, or testosterone. The yeast strain
SCW-ERE did not exhibit increased P-
galactosidase activity when incubated with
the various compounds listed above (data
not shown). This was expected because
yeast do not contain a naturally responsive
estrogen receptor. In contrast, the ,-galac-
tosidase activity of yeast strain hER-ERE
was significantly increased after treatment
with estradiol, DES, o,p'-DDT, or OP, but
not with ICI 164,384, dexamethasone, or
testosterone (Fig. 1). These results indicate
that the ,B-galactosidase activity of yeast
strain hER-ERE was selectively increased
after treatment with natural estrogens or
xenoestrogens. A protein extract was pre-
pared after strain hER-ERE was incubated
in the presence or absence ofestradiol. The
extract was separated by sodium dodecyl
sulfate-gel electrophoresis and transferred
to a polyvinylidenefluoride membrane for
Western blot analysis. The extract con-
tained similar levels ofhER in the presence
and absence of estradiol or xenoestrogens
(data not shown).
To more precisely define the potency of
the various estrogens in strain hER-ERE, a
dose-response experiment, with various
concentrations of the estrogens, was per-
formed. The EC50 (the concentration
required for 50% transcription) ofestradiol
and DES was approximately 0.2 nM (Fig.





Figure 1. ,-Galactosidase activity of yeast strain
hER-ERE aftertreatmentwith various compounds.
Strain hER-ERE was grown overnight in the pres-
ence of various compounds at a concentration of
10 pM. The activity of ,B-galactosidase was mea-
sured the next morning and was calculated as
Miller units as described in Materials and
Methods. Each value represents the mean of
three independent experiments with three repli-
cates. DES, diethylstilbestrol; OP, octyl phenol;
DEX, dexamethasone; T, testosterone.
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Figure 2. A dose-response curve of yeast strain
hER-ERE after treatment with increasing concen-
trations of 17p-estradiol, diethylstilbestrol (DES),
o,p'-DDT or octyl phenol (OP). Strain hER-ERE was
grown overnight in the presence of the indicated
estrogens at increasing concentrations. The
activity of )-galactosidase was measured the
next morning and was calculated as Miller units
as described in Materials and Methods. Each
value is the mean of three independent experi-
ments with three replicates.
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0.2 nM, indicating that the EC50 measured
in yeast is within physiological range
(unpublished data). The EC50 for o,p'-
DDT and OP was 200 nM, or 1,000-fold
greater than estradiol and DES. These
results are also consistent with the affinity
of o,p'-DDT and OP for the estrogen
receptor, calculated at 1,000-fold less than
estradiol.
Bioavailability ofEstrogens in the
YES System with Human Albumin
and SHBG
To evaluate the bioavailability of natural
estrogens compared to xenoestrogens, yeast
strain hER-ERE was grown in the presence
ofhuman albumin or SHBG and estradiol,
DES, o,p'-DDT, or OP. Human albumin
at 200 mg/ml almost completely eliminat-
ed the increase in0-galactosidase activity in
the presence of 17p-estradiol (Fig. 3).
Normal serum albumin levels in adult
males and females average 45 mg/ml and
41 mg/ml, respectively (19). A dose-
response curve with various concentrations
of albumin indicated that the IC 0 (the
concentration required to inhibit 3-galac-
tosidase activity by 50%) was 12.5 mg/ml.
Albumin was a less effective inhibitor ofj-
galactosidase activity in the presence of
DES, o>p'-DDT, and OP, with an IC50 of
approximately 100 mg/ml. Albumin was
1.7-fold more effective in reducing 3-galac-
tosidase activity in the presence ofestradiol
compared to DES, o,p'-DDT, and OP.
SHBG was significantly more effective
than albumin in reducing ,B-galactosidase
activity. The IC50 for SHBG was 0.035
mg/ml for estradiol, 0.15 mg/ml for DES,
o,p'-DDT, and 0.1 mg/ml for OP (Fig. 4).
Normal serum concentrations ofSHBG in
nonpregnant females and males range from
0.003-0.015 mg/ml (20). The IC50 of
SHBG for estradiol was approximately
fourfold greater than for DES, o,p'-DDT,
and OP. The IC50 for SHBG was much
lower than the corresponding IC50 for
albumin, confirming that SHBG has a
greater affinity for estrogens than albumin.
These results demonstrate that xenoestro-
gens induce greater 3-galactosidase activity
than estradiol in the presence of albumin
or SHBG, suggesting that the availability
ofxenoestrogens is greater than estradiol in
the presence ofalbumin or SHBG.
Bioavailability ofEstrogens in the
YES System with Serum
We evaluated the availability of natural
estrogens and xenoestrogens in the pres-
ence of whole human or alligator serum.
The yeast strain hER-ERE was grown
overnight in the presence ofhuman or alli-
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Figure 3. P3-Galactosidase activity of yeast strain
hER-ERE after treatment with albumin and natural
or xenoestrogens. Strain hER-ERE was grown
overnight in the presence of increasing concentra-
tions of albumin and 17p-estradiol (10 nM), diethyl-
stilbestrol (DES; 10 nM), o,p'DDT (10 pM), or octyl
phenol (OP; 10 pM). The concentrations of the
xenoestrogens used in this assay were the lowest
concentration needed to induce 100% f3-galactosi-
dase activity in Figure 2. Concentrations of albumin
greater than 200 mg/mI were not used because
they signficantly inhibited yeast growth. P-galac-
tosidase activity was measured as described in
Materials and Methods and is expressed as a per-
centage of 100% transcription in the absence of
albumin. Each value is the mean of three indepen-
dent experiments with three replicates.
1713-estradiol, DES, o,p'-DDT, or OP.1-
Galactosidase activity induced by 1713-
estradiol was selectively inhibited with
human serum compared to DES, o,p'-
DDT, and OP (Fig. 5A). The IC50 for
human serum was 1.5 mg protein/mi for
1713-estradiol and 7 mg protein/ml for
DES, o,p'-DDT, and OP. The IC50 for
alligator serum was 2 mg protein/ml for
1713-estradiol, similar to the IC50 obtained
with human serum (Fig. SB). The concen-
trations of alligator serum used decreased
13-galactosidase activity by only 30-40%
(Fig. SB). Concentrations of serum greater
than 10 mg protein/ml were not used
because they substantially inhibited the
growth of the yeast (data not shown).
These results indicate that human and alli-
gator serum selectively decrease the 13-
galactosidase induced by 171-estradiol
compared to xenoestrogens. In addition,
the alligator serum appears to contain less
binding activity than human serum for
xenoestrogens, but not estradiol.
Discussion
We developed the YES system to identify
and characterize compounds that act as
estrogens through the binding of the hER.
The simplicity of this screen will allow not
only the identification of estrogens, but
also mechanistic studies with estrogens.
The YES system responded to the known
iestrog,ens 17R13-esradiol,T)F DES o,p'-DT,
125
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Figure 4. ,B-Galactosidase activity of yeast strain
hER-ERE after treatment with sex hormone bind-
ing globulin (SHBG) and natural or xenoestrogens.
Strain hER-ERE was grown overnight in the pres-
ence of increasing concentrations of SHBG and
17p-estradiol (10 nM), diethylstilbestrol (DES; 10
nM), o,p'-DDT (10 pM), or octyl phenol (OP; 10
pM). The concentrations of the xenoestrogens
used in this assay were the lowest concentration
needed to induce 100% ,B-galactosidase activity in
Figure 2. 0-galactosidase activity was measured
as described in Materials and Methods.
Concentrations of SHBG >0.1 mg/ml were not
used because they signficantly inhibited yeast
growth. f-galactosidase activity is expressed as a
percentage of 100% transcription in the absence
of SHBG. Each value is the mean of three inde-
pendent experiments with three replicates.
and OP, but not the antiestrogen ICI
164,384, dexamethasone, or testosterone.
A dose-response experiment with estradiol,
DES, o,p'-DDT, or OP indicated that the
EC50 values measured in yeast for the vari-
ous estrogens were consistent with their
affinity for the estrogen receptor.
Interestingly, the EC50 for o,p'-DDT and
OP is 200 nM, well within the reported
population exposure of these compounds
(6,21,22). Our results and reports from
other laboratories indicate that the activa-
tion of estrogen receptors by estrogen is
similar in yeast and mammalian cells (23;
Arnold and McLachlan, unpublished data).
There are several advantages of the YES
system compared to mammalian cells: 1)
yeast are inexpensive to maintain, 2) the
expression and reporter plasmids in the
yeast strain are maintained by growth in
selective media, and 3) the 1-galactosidase
assay is straightforward and allows for
large-scale screening of compounds. The
potential disadvantage ofthe YES system is
that it is unclearwhetheryeastwill metabo-
lize proestrogens to estrogens. Therefore,
the results in the YES system will require
confirmation in mammalian cells.
The inclusion ofalbumin or SHBG in
the YES system selectively decreased 1-
galactosidase activity induced by estradiol
compared to the ecoestrogens, DES, op'-
DDT and OP. The same results were
Volume 104, Number5, May 1996 * Environmental Health Perspectives
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Figure 5. 3-Galactosidase activity of yeast strain hER-ERE after treatment with (A) human or (B) alligator
serum and natural estrogens or xenoestrogens. Strain hER-ERE was grown overnight in the presence of
increasing concentrations of human or alligatorwhole charcoal-stripped serum and 17f-estradiol (10 nM),
diethylstilbestrol (DES; 10 nM), o,p'-DDT (10 mM), or octyl phenol (OP;10 mM). The concentrations of the
xenoestrogens used in this assay were the lowest concentration needed to induce 100% P-galactosidase
activity in Figure 2. Concentrations of serum >7.5 mg protein/ml were not used because they signficantly
inhibited yeast growth. J-Galactosidase activity was measured as described in Materials and Methods
and is expressed as a percentage of 100% transcription in the absence of serum. Each value is the mean
ofthree independent experiments with three replicates.
obtained using human and alligator sera.
Our results are consistent with those
observed by vom Saal et al. (15), who used
MCF7 cells to assess the bioavailability of
estradiol, DES, o,p'-DDT, and methoxy-
chlor. They reported that DES and o,p'-
DDT were more available in serum com-
pared to serum-free media than estradiol
and methoxychlor, thus stimulating greater
cell proliferation. Together, these results
begin to provide the framework needed to
determine the basis by which the estro-
genicity ofcompounds is calculated. It sug-
gests that numerous factors are involved.
First, the binding affinity is important for
determining the interaction of the ligand,
in this case estrogens, with their receptor at
the molecular level. Second, the availability
of the ligand in serum will influence the
concentration at the target cell. The con-
centration at the target cell will determine
the degree of responsiveness produced by
that cell. o,p'-DDT and OP are classified
as weak estrogens because their binding
affinity for the estrogen receptor is 1,000-
fold lower than estradiol. However, if the
bioavailability ofDES, o,p'-DDT, and OP
is greater than estradiol in biological sys-
tems, the estrogenicity ofthese compounds
relative to estradiol would be enhanced.
This enhancement would be further mag-
nified if the compounds were not readily
degraded and bioaccumulated in the body
or iftheypersisted in the serum or cytosol.
The observation that alligator serum
has a lower binding activity for xenoestro-
gens when compared to human serum
could indicate a species-specific difference
in sensitivity. The differences noted
between alligator and human sera could be
accounted for by differences in plasma pro-
tein composition. Human serum is known
to have a specific sex hormone binding
protein (20) as does alligator serum (24;
Crain and Guillette, unpublished data).
The concentration of the SHBG in alliga-
tors is reduced during the breeding season
(24), when the serum used was obtained.
However, the concentration of SHBG in
alligator serum was comparable to that
reported for human serum (20,24). As far
as we know, only one report exists on the
concentration of SHBG in alligators (24),
and therefore this area awaits further
research. The differences in response could
be due to either seasonal variation in serum
protein composition or to species-specific
differences in serum protein composition
rather than to the absence ofsex hormone
binding proteins in alligators.
It is important to note that the IC50
values for human and alligator sera with
17,-estradiol were approximately equiva-
lent. This leads us to conclude that the dif-
ferences in serum binding with xenoestro-
gens is due to species-specific differences in
serum protein composition. Nevertheless,
our data suggest that a bioassay could be
developed to measure the sensitivity of a
species to xenoestrogens by testing a
species' serum for binding activity in the
YES system. Use ofwhole serum from vari-
ous species would provide data on inter-
species variation in the potential bioavail-
ability of xenoestrogens. With respect to
the alligator, whole serum rather than the
individual binding proteins was used
because the identification and characteriza-
tion ofbinding proteins has been very lim-
ited (24). Importantly, it is the binding
characteristics ofwhole serum, not a single
plasma protein, that will define the
bioavailability ofxenoestrogens. This infor-
mation, coupled with data on the capacity
ofthe estrogen receptor to recognize specif-
ic xenoestrogens, and the concentrations of
various xenoestrogens in a species' environ-
ment, could be predictive of potential
health risks.
The impact of xenoestrogens on the
health of humans and wildlife will require
identifying the differences between natural
estrogens and xenoestrogens. Several dis-
tinctions between natural estrogens and
xenoestrogens are beginning to emerge.
Data to date indicate that xenoestrogens
are metabolized at a significantly slower
rate than estradiol, suggesting that xenoe-
strogens may accumulate in lipids or persist
in serum to concentrations sufficient to
activate the estrogen receptor. In addition,
slower metabolism may account for the
increased nuclear retention of the estrogen
receptor after binding xenoestrogens com-
pared to estradiol. As shown in this study,
the bioavailability of xenoestrogens in
serum is apparently greater than that of
estradiol.
In conclusion, the YES system can be
used to identify and characterize xenoestro-
gens. The xenoestrogens tested have greater
bioavailability in serum than estradiol,
indicating a fundamental difference
between natural estrogens and some xeno-
estrogens. We hypothesize that increased
availability of xenoestrogens in serum
would lead to a greater response at the cel-
lular level. The difference in the ability of
human and alligator serum to bind xenoes-
trogens may indicate that a species-specific
sensitivity to xenoestrogens exists. In addi-
tion, future studies need to be performed
on the binding affinity of the estrogen
receptor from various species for the xenoe-
strogens found in their environment. For
as we have proposed, the estrogenicity of
various xenoestrogens depends on their
availability, metabolism, and binding affin-
ity to the estrogen receptor.
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